Champions Oncology Inc logo

Champions Oncology Inc

$ 7.68 -0.22 (-2.78%) 10:08 PM EST
P/E:
384.00
P/B:
11.56
Market Cap:
$ 103.85M
Enterprise V:
$ 108.00M
Volume:
8.78K
Avg Vol (2M):
11.71K
Also Trade In:
Volume:
8.78K
Market Cap $:
103.85M
PE Ratio:
384.00
Avg Vol (2-Month):
11.71K
Enterprise Value $:
108.00M
PB Ratio:
11.56
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Champions Oncology Inc is a us-based company which is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies.
Name Current Vs Industry Vs History
Cash-To-Debt 0.87
Equity-to-Asset 0.26
Debt-to-Equity 1.03
Debt-to-EBITDA 3.95
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 7/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.18
Distress
Grey
Safe
Beneish M-Score -3.23
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 26.78
9-Day RSI 36.52
14-Day RSI 40.11
12-1 Month Momentum % -18.74

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.11
Quick Ratio 1.11
Cash Ratio 0.48
Days Sales Outstanding 36.26
Days Payable 46.1

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -5.2

Financials (Next Earnings Date:2022-12-13 Est.)

CSBR's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:CSBR

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 51.601
EPS (TTM) ($) 0.02
Beta 0.41
Volatility % 27.43
14-Day RSI 40.11
14-Day ATR ($) 0.451421
20-Day SMA ($) 8.02912
12-1 Month Momentum % -18.74
52-Week Range ($) 6.81 - 10.6
Shares Outstanding (Mil) 13.52

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Champions Oncology Inc Filings

Document Form Filing Date
No Filing Data

Champions Oncology Inc Analysis

Share your research

Headlines

See More
No news.